MET and acute kidney injury: Therefore, in this study, we investigated the involvement of the HGF/Met pathway in AKI and whether treatment with cMet agonistic Ab improves the incidence, severity and course of AKI in a bilateral ischaemia‐reperfusion injury (IRI) model and an in vitro model with human PTECs (hPTECs) and GEnCs.